Recruitment

Recruitment Status
Unknown status

Inclusion Criterias

Vessel size in between 2.5 and 4.0 mm.
Acute MI with ST-segment elevation, within 12 hours from symptoms onset.
Signed patient informed consent.
...
Vessel size in between 2.5 and 4.0 mm.
Acute MI with ST-segment elevation, within 12 hours from symptoms onset.
Signed patient informed consent.
Length of culprit lesion≤25mm.
Age: 18-75 years

Exclusion Criterias

Prior administration of thrombolytic therapy.
Allergy to heparin, aspirin, clopidogrel, everolimus, the polymer components of the Xience V stent, stainless steel, or contrast media.
Cardiogenic shock.
...
Prior administration of thrombolytic therapy.
Allergy to heparin, aspirin, clopidogrel, everolimus, the polymer components of the Xience V stent, stainless steel, or contrast media.
Cardiogenic shock.
Multi-vessel lesion
Recent major bleeding.
Renal failure (Crea≥2.0mg/dL).
Left main disease
Angiography demonstrates the infarct lesion to be at the site of a previously implanted stent or in bypass grafts.
No suitable anatomy for OCT scan.
Other hemodynamically significant lesion(s) is present in the infarct vessel (or side branches)

Summary

Conditions
Acute Myocardial Infarction
Type
Interventional
Phase
Phase 4
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 75 years
Gender
Both males and females

Inclusion Criterias

Vessel size in between 2.5 and 4.0 mm.
Acute MI with ST-segment elevation, within 12 hours from symptoms onset.
Signed patient informed consent.
...
Vessel size in between 2.5 and 4.0 mm.
Acute MI with ST-segment elevation, within 12 hours from symptoms onset.
Signed patient informed consent.
Length of culprit lesion≤25mm.
Age: 18-75 years

Exclusion Criterias

Prior administration of thrombolytic therapy.
Allergy to heparin, aspirin, clopidogrel, everolimus, the polymer components of the Xience V stent, stainless steel, or contrast media.
Cardiogenic shock.
...
Prior administration of thrombolytic therapy.
Allergy to heparin, aspirin, clopidogrel, everolimus, the polymer components of the Xience V stent, stainless steel, or contrast media.
Cardiogenic shock.
Multi-vessel lesion
Recent major bleeding.
Renal failure (Crea≥2.0mg/dL).
Left main disease
Angiography demonstrates the infarct lesion to be at the site of a previously implanted stent or in bypass grafts.
No suitable anatomy for OCT scan.
Other hemodynamically significant lesion(s) is present in the infarct vessel (or side branches)

Locations

Harbin, Heilongjiang, 150081
Harbin, Heilongjiang, 150081

Tracking Information

NCT #
NCT01875835
Collaborators
Not Provided
Investigators
  • Principal Investigator: Bo Yu, MD,PhD The Second Affiliated Hospital of Harbin Medical University
  • Bo Yu, MD,PhD The Second Affiliated Hospital of Harbin Medical University